The Impact of Influenza on US Working-Age Adults: Exploring the Benefits of the Recombinant Influenza Vaccine
Influenza significantly affects US working-age adults, particularly those aged 50-64 years. Increases in longevity and chronic conditions prevalence are expected, making tailored public health vaccine recommendations important to support healthy aging.
Authors
- Laurent Coudeville (ORCID: https://orcid.org/0000-0003-3651-2959)
- Sandra S. Chaves (ORCID: https://orcid.org/0000-0002-9453-7057)
- Laurence Torcel‐Pagnon
- Rebecca C. Harris (ORCID: https://orcid.org/0000-0002-2636-1520)
Institutions
- Veterans Health Administration (US)
- Sanofi (France) (FR)
- Global Vaccines (United States) (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1093/cid/ciaf200
- Citations
- 3
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.06
Funders
- Sanofi